RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction

ABSTRACT Cumulative verified experimental studies have demonstrated that microRNAs (miRNAs) could be closely related with the development and progression of human complex diseases. Based on the assumption that functional similar miRNAs may have a strong correlation with phenotypically similar diseases and vice versa, researchers developed various effective computational models which combine heterogeneous biologic data sets including disease similarity network, miRNA similarity network, and known disease-miRNA association network to identify potential relationships between miRNAs and diseases in biomedical research. Considering the limitations in previous computational study, we introduced a novel computational method of Ranking-based KNN for miRNA-Disease Association prediction (RKNNMDA) to predict potential related miRNAs for diseases, and our method obtained an AUC of 0.8221 based on leave-one-out cross validation. In addition, RKNNMDA was applied to 3 kinds of important human cancers for further performance evaluation. The results showed that 96%, 80% and 94% of predicted top 50 potential related miRNAs for Colon Neoplasms, Esophageal Neoplasms, and Prostate Neoplasms have been confirmed by experimental literatures, respectively. Moreover, RKNNMDA could be used to predict potential miRNAs for diseases without any known miRNAs, and it is anticipated that RKNNMDA would be of great use for novel miRNA-disease association identification.

[1]  Zhu-Hong You,et al.  PBHMDA: Path-Based Human Microbe-Disease Association Prediction , 2017, Front. Microbiol..

[2]  Zhu-Hong You,et al.  A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..

[3]  Xing Chen,et al.  Long non-coding RNAs and complex diseases: from experimental results to computational models , 2016, Briefings Bioinform..

[4]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[5]  Xing Chen,et al.  IRWRLDA: improved random walk with restart for lncRNA-disease association prediction , 2016, Oncotarget.

[6]  Yongdong Zhang,et al.  Drug-target interaction prediction: databases, web servers and computational models , 2016, Briefings Bioinform..

[7]  Xing Chen,et al.  NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning , 2016, PLoS Comput. Biol..

[8]  Xing Chen,et al.  FMLNCSIM: fuzzy measure-based lncRNA functional similarity calculation model , 2016, Oncotarget.

[9]  Keith C. C. Chan,et al.  Sequence-based prediction of protein-protein interactions using weighted sparse representation model combined with global encoding , 2016, BMC Bioinformatics.

[10]  Zhu-Hong You,et al.  ILNCSIM: improved lncRNA functional similarity calculation model , 2016, Oncotarget.

[11]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[12]  Xing Chen.  miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. , 2016, Molecular bioSystems.

[13]  Jinfeng Zou,et al.  Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer. , 2016, JAMA oncology.

[14]  Zhu-Hong You,et al.  Detection of Interactions between Proteins through Rotation Forest and Local Phase Quantization Descriptors , 2015, International journal of molecular sciences.

[15]  Qionghai Dai,et al.  RBMMMDA: predicting multiple types of disease-microRNA associations , 2015, Scientific Reports.

[16]  Qionghai Dai,et al.  Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity , 2015, Scientific Reports.

[17]  Xia Li,et al.  Prediction of potential disease-associated microRNAs based on random walk , 2015, Bioinform..

[18]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[19]  M. Berry.  Esophageal cancer: staging system and guidelines for staging and treatment. , 2014, Journal of thoracic disease.

[20]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[21]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[22]  Jan Gorodkin,et al.  Protein-driven inference of miRNA–disease associations , 2013, Bioinform..

[23]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[24]  Ryan M. Layer,et al.  Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells , 2013, Oncogene.

[25]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[26]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[27]  Mohammed Al-Shalalfa,et al.  Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures , 2013, BMC Bioinformatics.

[28]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[29]  Edwin Wang,et al.  Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance. , 2013, Seminars in cancer biology.

[30]  Edwin Wang,et al.  Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks. , 2013, Seminars in cancer biology.

[31]  R. Dahiya,et al.  microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer , 2013, British Journal of Cancer.

[32]  G. Darling,et al.  MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. , 2012, The Annals of thoracic surgery.

[33]  M. Gazouli,et al.  Circulating MicroRNA in inflammatory bowel disease. , 2012, Journal of Crohn's & colitis.

[34]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[35]  Q. Cui,et al.  Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier , 2012, PloS one.

[36]  Wujian Peng,et al.  Reduced Circulating miR-15b Is Correlated with Phosphate Metabolism in Patients with End-Stage Renal Disease on Maintenance Hemodialysis , 2012, Renal failure.

[37]  Lixu Yan,et al.  [Serum miR-103 as a potential diagnostic biomarker for breast cancer]. , 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[38]  Wen-Tsung Huang,et al.  MicroRNA-21-mediated regulation of Sprouty2 protein expression enhances the cytotoxic effect of 5-fluorouracil and metformin in colon cancer cells. , 2012, International journal of molecular medicine.

[39]  F. Sarkar,et al.  MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. , 2012, Carcinogenesis.

[40]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[41]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[42]  David I. Watson,et al.  Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells , 2011, Journal of Gastrointestinal Surgery.

[43]  Y. Doki,et al.  Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway , 2011, Clinical Cancer Research.

[44]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[45]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[46]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[47]  A. Schetter,et al.  MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival , 2009, Clinical Cancer Research.

[48]  Thorsten Joachims,et al.  Cutting-plane training of structural SVMs , 2009, Machine Learning.

[49]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[50]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[51]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[52]  S. Barik,et al.  Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells , 2008, Journal of Molecular Medicine.

[53]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[54]  T. Tammela,et al.  MicroRNA expression profiling in prostate cancer. , 2007, Cancer research.

[55]  O. Sheils,et al.  Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model , 2007, Molecular cancer.

[56]  Frank J. Slack,et al.  The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.

[57]  Q. Cui,et al.  Principles of microRNA regulation of a human cellular signaling network , 2006, Molecular systems biology.

[58]  Thorsten Joachims,et al.  Training linear SVMs in linear time , 2006, KDD '06.

[59]  Xantha Karp,et al.  Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.

[60]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[61]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[62]  Thorsten Joachims,et al.  A support vector method for multivariate performance measures , 2005, ICML.

[63]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[64]  Peizhang Xu,et al.  MicroRNAs and the regulation of cell death. , 2004, Trends in genetics : TIG.

[65]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[66]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[67]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[68]  A. Polednak,et al.  Trends in survival for both histologic types of esophageal cancer in U.S. surveillance, epidemiology and end results areas , 2003, International journal of cancer.

[69]  B. Stewart,et al.  World Cancer Report , 2003 .

[70]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[71]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[72]  Thorsten Joachims,et al.  Making large scale SVM learning practical , 1998 .